<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lackenby</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Besselaar</surname>
    <given-names>T. G.</given-names>
   </name>
   <name>
    <surname>Daniels</surname>
    <given-names>R. S.</given-names>
   </name>
   <name>
    <surname>Fry</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Gregory</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Gubareva</surname>
    <given-names>L. V.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2018</year>). 
  <article-title>Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.</article-title>
  <source>
   <italic>Antiviral Res.</italic>
  </source>
  <volume>157</volume>
  <fpage>38</fpage>â€“
  <lpage>46</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.07.001</pub-id>
  <?supplied-pmid 29981793?>
  <pub-id pub-id-type="pmid">29981793</pub-id>
 </mixed-citation>
</ref>
